Skip to main content
Have a personal or library account? Click to login
Biological evaluation of transdichloridoplatinum( II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin Cover

Biological evaluation of transdichloridoplatinum( II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

Radiology and Oncology
Volume 47 (2013): Issue 4 (December 2013)
By: ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Oct 2013
References

References

  1. 1. O’Dwyer PJ, Stevenson JP, Johnson SW. Clinical status of cisplatin, carboplatin and other platinum-based antitumor drugs. In: Lippert B, editor.. Weinheim, Germany: Wiley-VCH; 1999. p. 30-70.
    Search in Google Scholar
  2. 2. Kelland L. The resurgence of platinum-based cancer chemotherapy.2007;573-84.
    Open DOISearch in Google Scholar
  3. 3. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment.2002;317-25.
    Open DOISearch in Google Scholar
  4. 4. Reedijk J. Metal-ligand exchange kinetics in platinum and ruthenium complexes.2008;2-11.
    Open DOISearch in Google Scholar
  5. 5. Wang, X. Fresh platinum complexes with promising antitumor activity.2010;396-411.
    Open DOISearch in Google Scholar
  6. 6. Farrell N, Kelland LR, Robert JD. Van Beusichem M. Activation of thegeometry in platinum antitumor complexes: a survey of the cytotoxicity ofcomplexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.1992;5065-72.
    Search in Google Scholar
  7. 7. Quiroga AG. Understandingplatinum complexes as potential antitumor drugs beyond targeting DNA.2012;106-12.
    Open DOISearch in Google Scholar
  8. 8. Coluccia M, Nassi A, Loseto F, Boccarell A, Mariggiò MA, Giordano D, et al. A-platinum complex showing higher antitumor activity than thecongeners.1993;510-2.
    Open DOISearch in Google Scholar
  9. 9. Radulović S, Tesić Ž, Manić, S.-platinum complexes as anticancer drugs: recent developments and future prospects.2002;1611-8.
    Open DOISearch in Google Scholar
  10. 10. Pérez JM, Montero EI, González AM, Solans X, Font-Bardia M, Fuertes MA, et al. X-Ray structure of cytotoxic-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition.2000;2411-8.
    Open DOISearch in Google Scholar
  11. 11. Arandjelović S, Tesić Ž, Juranić Z, Radulović S, Vrvić M, Potkonjak B, et al. Antiproliferative activity of some-/-platinum(II) complexes on HeLa cells.2002;519-26.
    Search in Google Scholar
  12. 12. Aris SM, Farrell N. Towards antitumor active-platinum compounds.2009;1293-302.
    Search in Google Scholar
  13. 13. Wang, X. Fresh platinum complexes with promising antitumor activity.2010;396-411.
    Open DOISearch in Google Scholar
  14. 14. Cubo L, Quiroga AG, Zhang J, Thomas DS, Carnero A, Navarro-Ranninger C, et al. Influence of amine ligands on the aquation and cytotoxicity ofdiamine platinum(II) anticancer complexes.2009;3457-66.
    Open DOISearch in Google Scholar
  15. 15. Reed E. ERCC1 and clinical resistance to platinum-based therapy.2005;6100-2.
    Open DOISearch in Google Scholar
  16. 16. Manić S, Gatti L, Carenini N, Fumagalli G, Zunino F, Perego P. Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.2003;21-9.
    Open DOISearch in Google Scholar
  17. 17. Kalayda GV, Wagner CH, Jaehde U. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.2012,1-10.
    Open DOISearch in Google Scholar
  18. 18. Sadler PJ. Protein recognition of platinated DNA.2009;73-4.
    Open DOISearch in Google Scholar
  19. 19. Ravera M, Gabano E, Sardi M, Ermondi G, Caron G, McGlinchey MJ, et al. Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.2011;400-9.
    Open DOISearch in Google Scholar
  20. 20. Ramos-Lima FJ, Moneo V, Quiroga AG, Carnero A, Navarro-Ranninger C. The role of p53 in the cellular toxicity by active-platinum complexes containing isopropylamine and hydroxymethylpyridine.2010;134-41.
    Open DOISearch in Google Scholar
  21. 21. Huq F, Yu JQ, Daghriri H, Beale P. Studies on activities, cell uptake and DNA binding of four-planaramineplatinum(II) complexes of the form:- PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-alpha)pyridine.2004;1261-70.
    Open DOISearch in Google Scholar
  22. 22. Aris SM, Knott KM, Yang X, Gewirtz DA, Farrell NP. Modulation of transplanaramine platinum complex reactivity by systematic modification of carrier and leaving groups.2009;929-34.
    Open DOISearch in Google Scholar
  23. 23. Rakić GM, Grgurić-Sipka S, Kaluderović GN, Gómez-Ruiz S, Bjelogrlić SK, Radulović SS, et al. Novel-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.2009;1921-5.
    Open DOISearch in Google Scholar
  24. 24. Kim KY, Jeong SY, Won J, Ryu PD, Nam MJ. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.2001;38781-6.
    Open DOISearch in Google Scholar
  25. 25. Muscella A, Calabriso N, Vetrugno C, Urso L, Fanizzi FP, De Pascali SA, et al. Sublethal concentrations of the platinum(II) complex [Pt(O,O’-acac) (gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.2010;1362-77.
    Open DOISearch in Google Scholar
  26. 26. Sasanelli R, Boccarelli A, Giordano D, Laforgia M, Arnesano F, Natile G, et al.Platinum complexes can inhibit matrix metalloproteinase activity: platinum- diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.2007;3434-41.
    Open DOISearch in Google Scholar
  27. 27. Montiel M, Urso L, de la Blanca EP, Marsigliante S, Jiménez E. Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity.2009;441-8.
    Open DOISearch in Google Scholar
  28. 28. Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-51970;168-70.
    Open DOISearch in Google Scholar
  29. 29. Gligorijević N, Aranđelović S, Filipović L, Jakovljević K, Janković R, GrgurićŠipka S, et al. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.2012;53-61.
    Open DOISearch in Google Scholar
  30. 30. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening.1990;1107-12.
    Open DOISearch in Google Scholar
  31. 31. Ormerod MG.New York: Oxford University Press; 1994.
    Search in Google Scholar
  32. 32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.1976;248-54.
    Open DOISearch in Google Scholar
  33. 33. Snoek-van Beurden PA, Von den Hoff JW. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.2005;73-83.
    Open DOISearch in Google Scholar
  34. 34. Musetti C, Nazarov AA, Farrell NP, Sissi C. DNA reactivity profile of transplatinum planar amine derivatives.2011;1283-90.
    Open DOISearch in Google Scholar
  35. 35. Altaha R, Liang X, Yu JJ, Reed E. Excision repair cross complementing-group 1: gene expression and platinum resistance.2004;959-70.
    Search in Google Scholar
  36. 36. Zorbas H, Keppler BK. Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?2005;1157-66.
    Search in Google Scholar
  37. 37. Ramos-Lima FJ, Vrána O, Quiroga AG, Navarro-Ranninger C, Halámiková A, Rybnícková H, et al. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.2006;2640 51.
    Open DOISearch in Google Scholar
  38. 38. Bierbach U, Sabat M, Farrell N. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.200;1882-90.
    Open DOISearch in Google Scholar
  39. 39. Wang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, et al. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.2011;24
    Open DOISearch in Google Scholar
  40. 40. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, et al. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.1996;556-62.
    Search in Google Scholar
  41. 41. Todd RC, Lippard SJ. Inhibition of transcription by platinum antitumor compounds.2009;280-91.
    Open DOISearch in Google Scholar
  42. 42. Seetharam RN, Sood A, Basu-Mallick A, Augenlicht LH, Mariadason JM, Goel S. Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.2010;2531-8.
    Search in Google Scholar
  43. 43. Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.2003;6321-32.
    Open DOISearch in Google Scholar
  44. 44. Arkell J, Jackson CJ. Constitutive secretion of MMP9 by early-passage cultured human endothelial cells.2003;381-6.
    Open DOISearch in Google Scholar
  45. 45. Ulukaya E, Ari F, Dimas K, Ikitimur KI, Yilmaz VT. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cellsand.2011;4957-63.
    Open DOISearch in Google Scholar
  46. 46. Kiran MS, Viji RI, Kumar SV, Prabhakaran AA, Sudhakaran PR. Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis.2011;6
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0050 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 346 - 357
Published on: Oct 8, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
angiogenesis,
apoptosis,
MMPs,
MRC-5,
trans-platinum(II)
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Lana Filipovic, Sandra Arandelovic, Nevenka Gligorijevic, Ana Krivokuca, Radmila Jankovic, Tatjana Srdic-Rajic, Gordana Rakic, Zivoslav Tesic, Sinisa Radulovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 4 (December 2013)
Previous article
Next article